SCHEMBL19157451

SCHEMBL19157451

C/C=C\C=C/C(C)=C/C(C)=N\C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17189452 0.83
SCHEMBL14987832 0.80
SCHEMBL20735146 0.80
SCHEMBL5369555 0.74 ALDH1A1 (0.41) PTGS1
SCHEMBL14192284 0.74 ALDH1A1 (0.41) PTGS1
SCHEMBL5369552 0.74 ALDH1A1 (0.41) PTGS1
SCHEMBL18966423 0.72
SCHEMBL11126174 0.72
SCHEMBL6702323 0.72
SCHEMBL23655148 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195861-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF DRY EYE DISORDERS SARcode Bioscience Inc. (US) 2017-07-26 EP disclosed